Aspire Biopharma Holdings Inc (ASBP)

Date: O: H: L: C: Vol:

Finanzdaten der Aspire Biopharma Holdings Inc-Aktie (ASBP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	122.57%0.06	0.03	0.00	0.00	-
Cost Of Revenue	124.83%0.05	0.02	0.01	0.00	-
Gross Profit	623.23%-0.03	0.01	-0.00	0.00	-
	60.31%2.65	1.65	1.85	1.15	0.80
Research and Development	21.31%0.23	0.30	0.10	0.21	0.35
Operating Income/Loss	62.69%-2.68	-1.65	-1.85	-1.15	-
Nonoperating Income/Loss	189.43%1.41	-1.58	-2.86	-0.70	-1.18
Income/Loss From Continuing Operations Before Tax	60.65%-1.27	-3.22	-	-1.85	-1.98
	60.65%-1.27	-3.22	-4.71	-1.85	-1.98
Attributable To Parent	60.65%-1.27	-3.22	-4.71	-1.85	-1.98
Basic Average Shares	562.40%1.04	0.16	-	49.53	-
Diluted Average Shares	562.40%1.04	0.16	-	49.53	-
Basic Earnings Per Share	94.07%-1.22	-20.57	-	-0.04	-
Diluted Earnings Per Share	94.07%-1.22	-20.57	-	-0.04	-